Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 912.60
+27.95 (3.16%)
Aug 21, 2026, 3:29 PM IST
Sakar Healthcare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 20,305 | 11,090 | 4,605 | 7,012 | 3,819 | 2,313 | |
Market Cap Growth | 191.15% | 140.84% | -34.33% | 83.60% | 65.09% | 30.97% |
Enterprise Value | 21,008 | 11,939 | 5,438 | 7,779 | 4,695 | 2,808 |
Last Close Price | 912.60 | 498.45 | 211.72 | 368.30 | 200.60 | 135.15 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 56.33 | 36.38 | 26.31 | 60.09 | 29.94 | 15.18 |
PS Ratio | 7.47 | 4.41 | 2.59 | 4.55 | 2.85 | 1.79 |
PB Ratio | 6.26 | 3.42 | 1.61 | 2.67 | 2.20 | 1.82 |
P/TBV Ratio | 6.40 | 3.50 | 1.64 | 2.69 | 2.20 | 1.82 |
P/FCF Ratio | 97.13 | 53.05 | 263.21 | - | - | - |
P/OCF Ratio | 41.22 | 22.52 | 13.53 | 28.66 | 11.46 | 9.39 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 7.72 | 4.74 | 3.05 | 5.05 | 3.50 | 2.17 |
EV/EBITDA Ratio | 27.16 | 17.33 | 10.95 | 19.78 | 13.77 | 10.04 |
EV/EBIT Ratio | 39.72 | 26.34 | 18.30 | 36.40 | 24.56 | 13.60 |
EV/FCF Ratio | 100.49 | 57.11 | 310.85 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.22 | 0.22 | 0.30 | 0.30 | 0.69 | 0.73 |
Debt / EBITDA Ratio | 0.91 | 1.02 | 1.74 | 2.02 | 3.49 | 3.32 |
Debt / FCF Ratio | - | 3.37 | 49.37 | - | - | - |
Net Debt / Equity Ratio | 0.22 | 0.22 | 0.30 | 0.30 | 0.67 | 0.67 |
Net Debt / EBITDA Ratio | 0.91 | 1.02 | 1.73 | 2.01 | 3.39 | 3.07 |
Net Debt / FCF Ratio | - | 3.36 | 49.19 | -2.25 | -2.37 | -7.86 |
Asset Turnover | - | 0.56 | 0.44 | 0.43 | 0.44 | 0.58 |
Inventory Turnover | - | 2.17 | 2.31 | 3.91 | 4.99 | 5.01 |
Quick Ratio | - | 0.46 | 0.49 | 0.36 | 0.47 | 0.46 |
Current Ratio | - | 1.28 | 1.40 | 1.21 | 1.03 | 1.07 |
Return on Equity (ROE) | - | 10.00% | 6.39% | 5.36% | 8.48% | 13.49% |
Return on Assets (ROA) | - | 6.32% | 4.62% | 3.69% | 3.96% | 5.79% |
Return on Invested Capital (ROIC) | 9.88% | 9.07% | 6.78% | 4.98% | 5.72% | 9.35% |
Return on Capital Employed (ROCE) | - | 12.20% | 8.40% | 6.50% | 6.80% | 9.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.78% | 2.75% | 3.80% | 1.66% | 3.34% | 6.59% |
FCF Yield | 1.03% | 1.88% | 0.38% | -5.00% | -12.79% | -4.71% |
Buyback Yield / Dilution | -1.20% | -1.07% | -6.20% | -11.49% | -23.33% | - |